Overview
TEM market data
Price History
TEM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.41 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.97 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $40.77 – $104.32 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $8K · P/B 21.38 · P/S 5.85.
Company News
Is Tempus AI Stock a Buy After Its CEO Sold 250,000 Shares?The Motley Fool · Jul 31, 2026, 3:15 PM
Tempus AI Stock Slides Friday: What's Driving the Post-Earnings Reset?Benzinga · Jul 31, 2026, 2:51 PM
Needham Reiterates Buy on Tempus AI, Maintains $75 Price TargetBenzinga · Jul 31, 2026, 9:12 AM
Why Nancy Pelosi-Owned Tempus AI Stock Is Down After Q2 EarningsBenzinga · Jul 30, 2026, 9:05 PM
Tempus AI Raises FY2026 Sales Guidance from $1.590B-$1.600B to $1.595B-$1.605B vs $1.593B EstBenzinga · Jul 30, 2026, 8:02 PM
Tempus AI Q2 Adj. EPS $(0.04) Beats $(0.14) Estimate, Sales $382.486M Beat $379.743M EstimateBenzinga · Jul 30, 2026, 8:01 PM
Halper Sadeh LLC is Investigating Whether FNWD and PSNL are Obtaining Fair Deals for their ShareholdersGlobenewswire Inc · Jul 30, 2026, 11:00 AM
Benzinga Bulls and Bears: IBM, Super Micro, TeslaBenzinga · Jul 25, 2026, 12:00 PM
Tempus AI Launches OneOme Pharmacogenomics Testing Solution, Delivering Advanced Genetic Insights To Optimize Medication Safety, Dosing And Toxicity Risk AssessmentBenzinga · Jul 22, 2026, 12:36 PM
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer MonitoringBenzinga · Jul 21, 2026, 6:52 PM